IT1282705B1 - Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria - Google Patents
Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinariaInfo
- Publication number
- IT1282705B1 IT1282705B1 IT96MI000378A ITMI960378A IT1282705B1 IT 1282705 B1 IT1282705 B1 IT 1282705B1 IT 96MI000378 A IT96MI000378 A IT 96MI000378A IT MI960378 A ITMI960378 A IT MI960378A IT 1282705 B1 IT1282705 B1 IT 1282705B1
- Authority
- IT
- Italy
- Prior art keywords
- treatment
- affinity
- receptor antagonists
- urinary incontinence
- ht1a
- Prior art date
Links
- 206010046543 Urinary incontinence Diseases 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 230000002295 serotoninergic effect Effects 0.000 title 1
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 abstract 2
- 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000017911 HTR1A Human genes 0.000 abstract 1
- 101150015707 HTR1A gene Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000026723 Urinary tract disease Diseases 0.000 abstract 1
- 102000030619 alpha-1 Adrenergic Receptor Human genes 0.000 abstract 1
- 108020004102 alpha-1 Adrenergic Receptor Proteins 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 230000001242 postsynaptic effect Effects 0.000 abstract 1
- 230000003518 presynaptic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000003727 serotonin 1A antagonist Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 208000014001 urinary system disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Spinning Or Twisting Of Yarns (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT96MI000378A IT1282705B1 (it) | 1996-02-28 | 1996-02-28 | Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria |
ES97906125T ES2213205T3 (es) | 1996-02-28 | 1997-02-25 | Uso de antagonistas del receptor 5-ht1a para el tratamiento de la incontinencia de orina. |
DK97906125T DK0906100T3 (da) | 1996-02-28 | 1997-02-25 | Anvendelse af 5-HT1A-receptorantagonister til behandling af urininkontinens |
AU20932/97A AU2093297A (en) | 1996-02-28 | 1997-02-25 | Use of 5-ht1a receptor antagonists for the treatment of urinary incontinence |
DE69727378T DE69727378T2 (de) | 1996-02-28 | 1997-02-25 | Verwendung von antagonisten des 5-htia rezeptors zur behandlung von harninkontinenz |
PT97906125T PT906100E (pt) | 1996-02-28 | 1997-02-25 | Utilizacao de antagonistas do receptor 5-hta1 no tratamento da incontinencia urinaria |
JP53057997A JP2001511763A (ja) | 1996-02-28 | 1997-02-25 | 尿失禁の治療のための5−ht▲下1a▼受容体アンタゴニストの使用 |
PCT/EP1997/000897 WO1997031637A1 (en) | 1996-02-28 | 1997-02-25 | Use of 5-ht1a receptor antagonists for the treatment of urinary incontinence |
EP97906125A EP0906100B1 (en) | 1996-02-28 | 1997-02-25 | Use of 5-ht 1a? receptor antagonists for the treatment of urinary incontinence |
AT97906125T ATE258438T1 (de) | 1996-02-28 | 1997-02-25 | Verwendung von antagonisten des 5-htia rezeptors zur behandlung von harninkontinenz |
US08/807,338 US5990114A (en) | 1996-02-28 | 1997-02-28 | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT96MI000378A IT1282705B1 (it) | 1996-02-28 | 1996-02-28 | Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria |
Publications (3)
Publication Number | Publication Date |
---|---|
ITMI960378A0 ITMI960378A0 (it) | 1996-02-28 |
ITMI960378A1 ITMI960378A1 (it) | 1997-08-28 |
IT1282705B1 true IT1282705B1 (it) | 1998-03-31 |
Family
ID=11373430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT96MI000378A IT1282705B1 (it) | 1996-02-28 | 1996-02-28 | Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0906100B1 (it) |
JP (1) | JP2001511763A (it) |
AT (1) | ATE258438T1 (it) |
AU (1) | AU2093297A (it) |
DE (1) | DE69727378T2 (it) |
DK (1) | DK0906100T3 (it) |
ES (1) | ES2213205T3 (it) |
IT (1) | IT1282705B1 (it) |
PT (1) | PT906100E (it) |
WO (1) | WO1997031637A1 (it) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6156780A (en) * | 1996-10-17 | 2000-12-05 | Milkhaus Laboratory, Inc. | Treatment of fecal incontinence |
SE510305C2 (sv) | 1997-05-30 | 1999-05-10 | Astra Ab | Nytt salt |
AU8130298A (en) * | 1997-07-15 | 1999-02-10 | Sankyo Company Limited | Piperazine derivatives |
US6906069B1 (en) | 1999-01-08 | 2005-06-14 | Amgen Inc. | LXR modulators |
WO2001060818A1 (en) * | 2000-02-14 | 2001-08-23 | Tularik Inc. | Lxr modulators |
US6673543B2 (en) | 2000-04-05 | 2004-01-06 | Tularik, Inc. | Solid phase synthesis of LXR ligands |
IL157363A0 (en) * | 2001-02-16 | 2004-02-19 | Aventis Pharma Inc | Novel heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
CN1558756A (zh) * | 2001-09-27 | 2004-12-29 | �ź㴫 | 用于治疗泌尿疾病的药物组合物 |
WO2003063796A2 (en) | 2002-01-30 | 2003-08-07 | Tularik Inc. | Heterocyclic arylsulfonamidobenzylic compounds |
CL2004000826A1 (es) | 2003-04-25 | 2005-03-04 | Pfizer | Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129 |
US20050165025A1 (en) * | 2004-01-22 | 2005-07-28 | Recordati Ireland Ltd. | Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists |
EP1847535A4 (en) * | 2005-02-04 | 2011-03-09 | Eisai R&D Man Co Ltd | 1- (piperidin-4-yl) -1H-indole derivatives |
JP4932717B2 (ja) | 2005-05-11 | 2012-05-16 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピペリジン環を有するインドール誘導体の製造方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU645681B2 (en) * | 1991-05-02 | 1994-01-20 | John Wyeth & Brother Limited | Piperazine derivatives |
EP0558245A1 (en) * | 1992-02-25 | 1993-09-01 | RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY | Heterobicyclic compounds as antagogists of alpha-1 adrenergic and SHT1A receptors |
GB9411099D0 (en) * | 1994-06-03 | 1994-07-27 | Wyeth John & Brother Ltd | Piperazine derivatives |
GB9417135D0 (en) * | 1994-08-23 | 1994-10-12 | Medinnova S F | Method |
-
1996
- 1996-02-28 IT IT96MI000378A patent/IT1282705B1/it active IP Right Grant
-
1997
- 1997-02-25 ES ES97906125T patent/ES2213205T3/es not_active Expired - Lifetime
- 1997-02-25 DK DK97906125T patent/DK0906100T3/da active
- 1997-02-25 AT AT97906125T patent/ATE258438T1/de not_active IP Right Cessation
- 1997-02-25 JP JP53057997A patent/JP2001511763A/ja not_active Ceased
- 1997-02-25 WO PCT/EP1997/000897 patent/WO1997031637A1/en active Search and Examination
- 1997-02-25 EP EP97906125A patent/EP0906100B1/en not_active Revoked
- 1997-02-25 PT PT97906125T patent/PT906100E/pt unknown
- 1997-02-25 DE DE69727378T patent/DE69727378T2/de not_active Revoked
- 1997-02-25 AU AU20932/97A patent/AU2093297A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0906100B1 (en) | 2004-01-28 |
WO1997031637A1 (en) | 1997-09-04 |
DE69727378T2 (de) | 2004-12-09 |
PT906100E (pt) | 2004-06-30 |
ATE258438T1 (de) | 2004-02-15 |
EP0906100A1 (en) | 1999-04-07 |
JP2001511763A (ja) | 2001-08-14 |
DE69727378D1 (de) | 2004-03-04 |
ITMI960378A1 (it) | 1997-08-28 |
DK0906100T3 (da) | 2004-05-03 |
ITMI960378A0 (it) | 1996-02-28 |
ES2213205T3 (es) | 2004-08-16 |
AU2093297A (en) | 1997-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA199800340A1 (ru) | Производные пиримидина как антагонисты 5нт2с | |
IT1282705B1 (it) | Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria | |
ATE234290T1 (de) | Phenylalkyl-imidazole als h3-rezeptor- antagonisten | |
AU9648098A (en) | Adenosine a3 receptor antagonists | |
BR1100680A (pt) | Antagonistas tricìclos de receptores de 5-ht3 | |
ES2162676T3 (es) | Derivados de fenileno sustituidos en meta y su uso como antagonistas o inhibidores de integrina alfav,beta3. | |
LV11688A (lv) | Morfolina tahikinina receptoru antagonistu priekstecvielas | |
EP1762236A3 (en) | Formulations of alpha adrenergic receptor antagonists and their uses | |
AU7406596A (en) | Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation and their use | |
IL149550A0 (en) | Bicyclic and tricyclic heteroaromatic compounds | |
DE69713582T2 (de) | Zimtsäurederivate und deren verwendung als integrin-antagonisten | |
PT776324E (pt) | Antagonista da endotelina | |
NO20012194D0 (no) | CRF-reseptorantagonister og tilhörende fremgangsmåter | |
BR9910144A (pt) | Antagonistas de receptores de quimiocinas e seu uso | |
FI960571A0 (fi) | Kolekystokiniini- ja gastriiniantagonisteina käyttökelpoisia bisyklo(2.2.2)oktaanijohdannaisia | |
ATE343578T1 (de) | Tri- und tetraaza-acenaphthylen-derivate als crf- rezeptor-antagonisten | |
IT1255461B (it) | Eteri di imidazoli ad attivita' a ii antagonista | |
AU2001263329A1 (en) | Crf receptor antagonists and methods relating thereto | |
IT1270611B (it) | Derivati eterociclo-condensati di morfinoidi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |